KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to $62.4 million.

  • Jazz Pharmaceuticals' Change in Account Payables rose 58755.28% to $62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.7 million, marking a year-over-year increase of 36233.23%. This contributed to the annual value of -$20.1 million for FY2024, which is 30902.84% down from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Change in Account Payables of $62.4 million as of Q3 2025, which was up 58755.28% from -$12.7 million recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Change in Account Payables registered a high of $62.4 million during Q3 2025, and its lowest value of -$32.0 million during Q2 2021.
  • For the 5-year period, Jazz Pharmaceuticals' Change in Account Payables averaged around $5.5 million, with its median value being -$142000.0 (2021).
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 2049366.2% in 2022, then crashed by 104251.58% in 2023.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Change in Account Payables stood at $37.9 million in 2021, then crashed by 140.72% to -$15.4 million in 2022, then surged by 47.43% to -$8.1 million in 2023, then soared by 61.31% to -$3.1 million in 2024, then surged by 2089.09% to $62.4 million in 2025.
  • Its Change in Account Payables was $62.4 million in Q3 2025, compared to -$12.7 million in Q2 2025 and $19.1 million in Q1 2025.